Mounjaro 7.5mg/0.5ml is a once-weekly injection used to manage blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, which targets GIP and GLP-1 receptors to enhance insulin response and reduce glucose levels. This intermediate dose supports gradual progression in therapy. Each pack includes 4 pre-filled pens for accurate, easy injection. Administer subcutaneously once per week under medical guidance.